Neurodegeneration: Microglia & TDP-43

TDP-43 is implicated in several neurodegenerative disorders including Alzheimer's disease, amyotrophic lateral sclerosis and frontotemporal lobe dementia. It has also been shown to regulate microglial phagocytosis. Here is the latest research on the role of TDP-43 and microglia in neurodegeneration.

September 1, 2020

Neurotoxic microglia promote TDP-43 proteinopathy in progranulin deficiency.

Jiasheng ZhangEric J Huang
July 8, 2020

Neuropathological profile of long-duration amyotrophic lateral sclerosis in military Veterans

Brain Pathology
Keith R SpencerThor D Stein
January 17, 2017
Open Access

M1 and M2 Functional Imprinting of Primary Microglia: Role of P2X7 Activation and miR-125b

Mediators of Inflammation
Chiara ParisiCinzia Volonté
July 4, 2017
Open Access

TDP-43 Depletion in Microglia Promotes Amyloid Clearance but Also Induces Synapse Loss

Rosa C PaolicelliLawrence Rajendran
September 21, 2018
Open Access

Subarachnoid hemorrhage enhances the expression of TDP-43 in the brain of experimental rats and human subjects

Experimental and Therapeutic Medicine
Tibiao HeFei Liu
February 22, 2018
Open Access

Microglia-mediated recovery from ALS-relevant motor neuron degeneration in a mouse model of TDP-43 proteinopathy

Nature Neuroscience
Krista J SpillerVirginia M-Y Lee
May 28, 2017
Case Report
Open Access

Microglial and Neuronal TDP-43 Pathology in Anti-IgLON5-Related Tauopathy

Journal of Alzheimer's Disease : JAD
Annachiara CagninSalvatore Monaco
July 10, 2018

FUS(1-359) transgenic mice as a model of ALS: pathophysiological and molecular aspects of the proteinopathy

Sergei Y FunikovAleksey A Ustyugov
September 28, 2020
Open Access

Systemic Inflammation Causes Microglial Dysfunction With a Mixed Ad-like Pathology

Praveen Bathinilavinia Alberi
October 2, 2018
Open Access

Enteroviral Infection Leads to Transactive Response DNA-Binding Protein 43 Pathology in Vivo

The American Journal of Pathology
Yuan Chao XueHonglin Luo
October 10, 2019

The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins

Vandana DeoraTrent M Woodruff
November 1, 2018
Open Access

Neuronal Expression of UBQLN2P497H Exacerbates TDP-43 Pathology in TDP-43G348C Mice through Interaction with Ubiquitin

Molecular Neurobiology
Vincent Picher-MartelJean-Pierre Julien
July 15, 2017
Comment / Editorial

Neurodegenerative disease: Loss of TDP-43 in microglia - friend or foe?

Nature Reviews. Neurology
Charlotte Ridler
September 15, 2019
Open Access

The endotoxin hypothesis of neurodegeneration

Journal of Neuroinflammation
Guy C Brown
November 1, 2019
Open Access

MCP1-CCR2 and neuroinflammation in the ALS motor cortex with TDP-43 pathology

Journal of Neuroinflammation
Javier H JaraP Hande Özdinler
March 18, 2017
Case Report

Frontotemporal Dementia due to the Novel GRN Arg161GlyfsX36 Mutation

Journal of Alzheimer's Disease : JAD
Stefano GazzinaBarbara Borroni
August 27, 2019
Open Access

Microglia in frontotemporal lobar degeneration with progranulin or C9ORF72 mutations

Annals of Clinical and Translational Neurology
Nobutaka SakaeDennis Dickson
April 15, 2017
Open Access

Spinal poly-GA inclusions in a C9orf72 mouse model trigger motor deficits and inflammation without neuron loss

Acta Neuropathologica
Martin H SchludiDieter Edbauer
November 11, 2018
Open Access

Age-related deregulation of TDP-43 after stroke enhances NF-κB-mediated inflammation and neuronal damage

Journal of Neuroinflammation
Sai Sampath ThammisettyJasna Kriz

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved